{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:20:59Z","timestamp":1788520859353,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","award":["MR\/K501074\/1"],"award-info":[{"award-number":["MR\/K501074\/1"]}],"id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","award":["515048"],"award-info":[{"award-number":["515048"]}],"id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011708","name":"SMA Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","nmd-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nmd.2024.104451","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T13:42:02Z","timestamp":1726407722000},"page":"104451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Spinal presentations in children with spinal muscular atrophy type 1 following gene therapy treatment with onasemnogene abeparvovec \u2013 The SMA REACH UK network experience"],"prefix":"10.1016","volume":"44","author":[{"given":"Amy","family":"Wolfe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Cranney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Stimpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Scoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasantha","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wraige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-3427","authenticated-orcid":false,"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2024.104451_bib0001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.nmd.2024.104451_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpeds.2012.05.067","article-title":"Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy","volume":"162","author":"Farrar","year":"2013","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.nmd.2024.104451_bib0003","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneur.59.9.1445","article-title":"Outcome measures for pediatric spinal muscular atrophy","volume":"59","author":"Iannaccone","year":"2002","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2024.104451_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(94)00075-K","article-title":"Chaos in the classification of SMA: a possible resolution","volume":"5","author":"Dubowitz","year":"1995","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2024.104451_bib0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nmd.2017.05.011","article-title":"Spinal muscular atrophy: a changing phenotype beyond the clinical trials","volume":"27","author":"Tizzano","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2024.104451_bib0006","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cpt.2247","article-title":"Prognostic factors and treatment-effect modifiers in spinal muscular atrophy","volume":"110","author":"Baranello","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nmd.2024.104451_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01367-y","article-title":"Natural history of lung function in spinal muscular atrophy","volume":"15","author":"Wijngaarde","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.nmd.2024.104451_bib0008","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1469-8749.1989.tb04029.x","article-title":"Scoliosis in spinal muscular atrophy: natural history and management","volume":"31","author":"Merlini","year":"1989","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"10","key":"10.1016\/j.nmd.2024.104451_bib0009","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.apmr.2004.01.043","article-title":"Joint range of motion limitations in children and young adults with spinal muscular atrophy","volume":"85","author":"Wang","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"10.1016\/j.nmd.2024.104451_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00132-021-04131-7","article-title":"Scoliosis in spinal muscular atrophy","volume":"50","author":"Vu-Han","year":"2021","journal-title":"Orthopade"},{"issue":"10","key":"10.1016\/j.nmd.2024.104451_bib0011","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.2106\/JBJS.RVW.20.00040","article-title":"Evaluation and treatment of early-onset scoliosis: a team approach","volume":"8","author":"Anari","year":"2020","journal-title":"JBJS Reviews"},{"issue":"4","key":"10.1016\/j.nmd.2024.104451_bib0012","first-page":"279","article-title":"Scoliosis in spinal muscular atrophy type 1 in the nusinersen era","volume":"12","author":"Al Amrani","year":"2022","journal-title":"Neurology: Clinical Practice"},{"key":"10.1016\/j.nmd.2024.104451_bib0013","doi-asserted-by":"crossref","unstructured":"De Figueiredo, A.M., Marques, R.P.G., Silva, A.C. and Silvestre, A.M.D.A.M. 6ER-007 Real-world effectiveness of gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy: a review. 2022; A169\u201370.","DOI":"10.1136\/ejhpharm-2022-eahp.357"},{"issue":"12","key":"10.1016\/j.nmd.2024.104451_bib0014","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy - insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.nmd.2024.104451_bib0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/1060028020914274","article-title":"Onasemnogene abeparvovec-xioi: gene therapy for spinal muscular atrophy","volume":"54","author":"Stevens","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nmd.2024.104451_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-14-283","article-title":"Natural course of scoliosis in proximal spinal muscular atrophy type II and IIIa: descriptive clinical study with retrospective data collection of 126 patients","volume":"14","author":"Fujak","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.nmd.2024.104451_bib0017","doi-asserted-by":"crossref","first-page":"e12138","DOI":"10.1002\/anr3.12138","article-title":"A case series of paediatric patients with spinal muscular atrophy type I undergoing scoliosis correction surgery","volume":"9","author":"Kong Kam Wa","year":"2021","journal-title":"Anaesthesia Reports"},{"issue":"6","key":"10.1016\/j.nmd.2024.104451_bib0018","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5435\/JAAOS-20-06-393","article-title":"Spinal muscular atrophy: manifestations and management","volume":"20","author":"Mesfin","year":"2012","journal-title":"JAAOS-J Am Acad Orthopaedic Surgeons"},{"issue":"9","key":"10.1016\/j.nmd.2024.104451_bib0019","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00007632-199009000-00019","article-title":"Surgical treatment of scoliosis in a spinal muscular atrophy population","volume":"15","author":"Phillips","year":"1990","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.nmd.2024.104451_bib0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/TCRM.S172291","article-title":"Clinical evidence supporting early treatment of patients with spinal muscular atrophy: current perspectives","volume":"15","author":"Dangouloff","year":"2019","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"10.1016\/j.nmd.2024.104451_bib0021","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1212\/WNL.0000000000007742","article-title":"Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy","volume":"93","author":"Wijngaarde","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2024.104451_bib0022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mus.27363","article-title":"Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy","volume":"64","author":"Kichula","year":"2021","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.nmd.2024.104451_bib0023","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00007632-198209000-00012","article-title":"Spinal deformities in patients with spinal muscle atrophy: a review of 36 patients","volume":"7","author":"Riddick","year":"1982","journal-title":"Spine"},{"issue":"2","key":"10.1016\/j.nmd.2024.104451_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2024.104451_bib0025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/children10060998","article-title":"Early development of spinal deformities in children severely affected with spinal muscular atrophy after gene therapy with onasemnogene abeparvovec\u2014preliminary results","volume":"10","author":"Soini","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.nmd.2024.104451_bib0026","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s43465-021-00438-x","article-title":"Repeated pelvic radiographs in infants, after harness treatment for developmental dysplasia of the hip, carry very low radiation risk","volume":"55","author":"Vogel","year":"2021","journal-title":"Indian J Orthop"},{"issue":"2","key":"10.1016\/j.nmd.2024.104451_bib0027","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JND-190462","article-title":"Scoliosis surgery significantly impacts motor abilities in higher-functioning individuals with spinal muscular atrophy","volume":"7","author":"Dunaway Young","year":"2020","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.nmd.2024.104451_bib0028","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1212\/WNL.0000000000011051","article-title":"Respiratory trajectories in type 2 and 3 spinal muscular atrophy in the iSMAC cohort study","volume":"96","author":"Trucco","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2024.104451_bib0029","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF00301032","article-title":"Scoliosis and lung function in spinal muscular atrophy","volume":"4","author":"Robinson","year":"1995","journal-title":"Eur Spine J"},{"key":"10.1016\/j.nmd.2024.104451_bib0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s43390-021-00302-w","article-title":"The impact of scoliosis surgery on pulmonary function in spinal muscular atrophy: a systematic review","volume":"9","author":"Alhammoud","year":"2021","journal-title":"Spine Deform"},{"issue":"1","key":"10.1016\/j.nmd.2024.104451_bib0031","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British Thoracic Society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.nmd.2024.104451_bib0032","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4103\/ija.IJA_312_20","article-title":"Peri-operative management of children with spinal muscular atrophy","volume":"64","author":"Halanski","year":"2020","journal-title":"Indian J Anaesth"},{"issue":"12","key":"10.1016\/j.nmd.2024.104451_bib0033","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/jor.24656","article-title":"Motor development in infancy and spine shape in early old age: findings from a British birth cohort study","volume":"38","author":"Saunders","year":"2020","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.nmd.2024.104451_bib0034","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.brs.0000149074.21550.32","article-title":"The evolution of sagittal segmental alignment of the spine during childhood","volume":"30","author":"Cil","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.nmd.2024.104451_bib0035","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00586-016-4828-2","article-title":"The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy type II patients","volume":"26","author":"Chou","year":"2017","journal-title":"Eur Spine J"},{"issue":"9","key":"10.1016\/j.nmd.2024.104451_bib0036","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1440-1754.2003.00266.x","article-title":"Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III","volume":"39","author":"Chng","year":"2003","journal-title":"J Paediatr Child Health"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624009477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896624009477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:08:59Z","timestamp":1731672539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896624009477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"alternative-id":["S0960896624009477"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2024.104451","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal presentations in children with spinal muscular atrophy type 1 following gene therapy treatment with onasemnogene abeparvovec \u2013 The SMA REACH UK network experience","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2024.104451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104451"}}